Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results

Go back to Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 4.18 +0.02 (0.48%)
Previous Close $4.16    52 Week High
Open $4.20    52 Week Low
Day High $4.21    P/E N/A 
Day Low $4.09    EPS
Volume 699,419